This study is testing the safety and effectiveness of an investigational medication. Investigational means that this medication has not yet been approved by the US FDA as safe or effective for any use. Qualified individuals may receive study medication during the study unless they experience any side effects requiring treatment discontinuation, with additional quarterly follow-ups as needed.
About The Company
BeiGene is a commercial-stage BioTech company focused on developing and commercializing innovative molecularly-targeted and immune-oncology drugs for the treatment of cancer.
Will I Benefit From Participating In This Study?
The study drug is an investigational product and you may or may not develop a benefit from the study drug. By participating in the Liver Cancer Study, you may:
Hepatocellular carcinoma (HCC) is a major global health problem, accounting for 85-90% of all reported cases of liver cancer. According to the World Health Organization, liver cancer was the sixth most common type of cancer in 2012, with 782,000 new cases worldwide. Liver cancer begins in the cells of your liver and most people don’t experience signs or symptoms in the early stages.
Symptoms may include:
You Or A Loved One May Qualify If You:
There are additional study requirements to participate. A study representative will discuss them with you.
A clinical research study tests the safety and effectiveness of a new medicine or treatment in a population of volunteers. All new drug products go through the clinical trial process, therefore, participants like you play a very important role in advancing medicine for present and future generations.
An investigational medication has been tested in the laboratory and the U.S. Food and Drug Administration (FDA) is allowing it to be tested in people. It is not approved as safe or effective by the FDA and thus is not approved for sale by the FDA or other government agencies. A clinical trial tests how well an investigational medication works and whether it is safe to use for a specific disease or disorder.
A clinical trial has a structured set of clinic visits, tests, and drug dosing schedules the patient must follow. Information about how you feel and how you are reacting to the study treatment is collected.
Protecting the health and safety of people who take part in clinical trials is the highest priority for clinical researchers throughout the entire study process. All clinical trials follow strict federal guidelines on how volunteers must be treated. All aspects of the study will be explained to you, and you will have the opportunity to ask questions.
You have the right to leave a clinical trial at any time, for any reason. If you decide to leave a trial, talk to your doctor first. You will want to know how leaving the trial might affect your health and what other treatment options may be available.
All current study locations are listed below and more may be added at any time. If you are interested in participating in the Liver Cancer study, complete the form to speak with a study representative regarding your eligibility and available study locations.
Dr. Charles Bane
Precision Cancer Research/Dayton Physicians Network – Treatment
3120 Governors Place Blvd
Kettering, OH 45409
Dr. Subramanya Rao
Healthcare Research Network III, LLC
17333 South La Grange Road
Tinley Park, IL
Dr. Dan Costin
White Plains Hospital Center for Cancer Care
2 Longview Ave.
White Plains, NY 10601
Dr. Tarek Hassanein
Southern California Research Center
131 Orange Avenue Suite 101
Coronado, CA 92118
Dr. Sukeshi Arora
Mays Cancer Center – Oncology
7979 Wurzbach Road Suite Z414
San Antonio, TX 78229
Dr. David Park
St. Jude Heritage Healthcare
2151 N. Harbor Blvd. Suite 2200
Fullerton, CA 92835
Dr. David Park
Monter Cancer Center
450 Lakeville Rd.
Lake Success, NY 11042